Center of Toxicology and Preclinical Sciences

InnoStar, also known as the Center of Toxicology and Preclinical Sciences (CTPS), is a premier Contract Research Organization (CRO) based in Shanghai, China, specializing in non-clinical safety assessment and preclinical evaluation. Established in 2003 as part of the Shanghai Institute of Materia Medica, the company provides a comprehensive suite of GLP-compliant services, including general toxicology, safety pharmacology, pharmacokinetics, and immunotoxicity testing. InnoStar is distinguished by its ability to support global regulatory submissions, maintaining compliance with NMPA, FDA, and OECD standards. The center's expertise encompasses a wide range of therapeutic modalities, from traditional small molecules to advanced biologics, vaccines, and cell and gene therapies. As a subsidiary of the China National Biotech Group (CNBG) under Sinopharm, InnoStar serves as a critical partner for pharmaceutical and biotechnology companies navigating the complexities of drug development and international market entry.